Standard
WHO Drops Hydroxychloroquine and Lopinavir/Ritonavir Arms from Solidarity Trial Following Interim Results
The World Health Organization has officially accepted a recommendation from the International Steering Committee of the Solidarity Trial to immediately discontinue the trial’s hydroxychloroquine and lopinavir/ritonavir treatment arms. The landmark Solidarity Trial was established by the global health body early in the course of the pandemic to find an effective, life-saving COVID-19 treatment specifically tailored…
